Novo Nordisk challenges Pfizer with a $6.5 billion bid for Metsera, aiming to outbid Pfizer's earlier offer and reshape the obesity drug market.
Supreme Court delays ruling on Trump's National Guard deployment to Illinois, seeking clarification on the scope of presidential authority to use troops for domestic law enforcement without state consent.
US ends automatic EAD extensions, affecting many migrant and temporary workers, as DHS aims to restore more robust screening and vetting.
Novo Nordisk challenges Pfizer with a $6.5 billion bid for Metsera, aiming to outbid Pfizer's earlier offer and reshape the obesity drug market.
Supreme Court delays ruling on Trump's National Guard deployment to Illinois, seeking clarification on the scope of presidential authority to use troops for domestic law enforcement without state consent.
US ends automatic EAD extensions, affecting many migrant and temporary workers, as DHS aims to restore more robust screening and vetting.